The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes

Journal of Diabetes and its Complications

Volumn 11, Issue 1, 1997, Pages 2-8

  Hibberd, M L ^a   Millward, B A ^a   Demaine, A G ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE DURATION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENE LOCUS; GENOTYPE; HOMOZYGOSITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LONGEVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL; VASCULAR DISEASE;

EID: 0031054997     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(95)00114-X     Document Type: Article

References (32)

1. 1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in type I (insulin dependent) diabetes: an epidemiological study. Diabetologia 25:496-501, 1983.
2. 2. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type I diabetes. Am J Med 78:785-794, 1985.
3. 3. Viberti GC, Walker JD: Diabetic nephropathy: Etiology and prevention. Diabetes Metab Rev 4:147-162, 1988.
4. 4. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165, 1989.
5. 5. Anderson S, Brenner BM: Pathogenesis of diabetic globerulopathy: haemodynamic considerations. Diabetes Metab Rev 4:163-177, 1988.
6. 6. Viberti GC, Keen H, Wiseman MJ: Raised arterial pressure in parents of proteinuric insulin dependent diabetics. B M J 295:515-517, 1987.
7. 7. Krolweski AS, Canessa M, Warram JH, Laffel LMB, Christlieb AR, Knowler WC, Rand LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318;140-145, 1988.
8. 8. Erdos EGL Angiotensin I-converting enzyme and the changes in our concepts through the years. Hypertension 16:363-370, 1990.
9. 9. Ballerman BJ, Zeidel ML, Gunning ME, Brenner BM: Vasoactive peptides and the kidney, in: Brenner Bm, Rector FC (Eds), The Kidney, 4th edition. Philadelphia, Saunders, 1991, pp. 510-583.
10. 10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrer F. An insertion deletion polymorphism in agntiotensin 1 converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990.
11. 11. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992.
12. 12. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin I-converting enzyme is a potent risk factor for mycardial infarction. Nature 359:641-644, 1992.
13. 13. Tirat L, Kee F, Poirer O, Nicaud V, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Amouyel P, Cambien F: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341:991-992, 1993.
14. 14. Marian AJ, Yu Q-T, Workman R, Greve G, Roberts R: Angiotensin-converting enzyme polymorphisms in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342:1085-1086, 1993.
15. 15. Evans AE, Poirer O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O'Rourke DF, Cambien F: Polymorphisms of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease. Q J M 87:211-214, 1994.
16. 16. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 91:3662-3665, 1994.
17. 17. Tarnow O, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Borch-Johnsen K, Parving H-H: Insertion/deletion polymorphism in the angiotensin I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 38:798-803, 1995.
18. 18. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene T-T, Hallab M, Cambien F, Passa P, Alhenic-Gelas F: Relationships between angiotensin 1 converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994.
19. 19. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43:690-695, 1994.
20. 20. Tarnow L, Cambien F, Possing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving H-H: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995.
21. 21. Schater F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D: Genetic associations with human longevity at the APOE and ACE loci. Nature Gen 6:29-32, 1994.
22. 22. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979.
23. 23. Hibberd ML, Millward BA, Wong FS, Demaine AG: T-cell receptor constant β-chain polymorphisms and susceptibility to type I diabetes. Diabetic Med 9:929-933, 1992.
24. 24. Patel A, Ratanachaiyavong S, Millward BA, Demaine AG: Polymorphisms of the aldose reductase locus (ALR2) and susceptibility to diabetic microvascular complications. Adv Exp Med Biol 328:325-332, 1993.
25. 25. Patel A, Hibberd ML, Millward BA, Demaine AG: Chromosome 7q35 and susceptibility to diabetic microvascular complications. J Diabet Complications 1996 (in press).
26. 26. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene. Nucleic Acids Res 20:1433, 1992.
27. 27. Krege JH, John SWM, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O: Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146-148, 1995.
28. 28. Kozlowski S, Corr M, Shirai M, Boyd LF, Pendleton CD, Berzofsky JA, Margulies DH; Multiple pathways are involved in the extracellular processing of MHC class I restricted peptides. J Immunol 151:4033-4044, 1993.
29. 29. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33-40, 1993.
30. 30. Ehlers MRW, Riordan JF: Angiotensin-converting enzyme: New concepts concerning its biological role. Biochemistry 28:5311-5313, 1989.
31. 31. Costerousse O, Jaspard E, Wei L, Corvol P, Alhene-Gelas F: The angiotensin I-converting enzyme (kiniase II): Molecular organisation and regulation of its expression in humans. J Cardiovasc Pharmacol 20(suppl 9): S10-15, 1992.
32. 32. McGeer EG, Singh EA: Angiotensin-converting enzyme in cortical tissue in Alzheimer's and some other neurological disease. Dementia 3:299-303, 1992.